Terrance P. Coyne, EVP & CFO: Royalty Pharma RPRX Sell · Filed 01/23

Trade details

Type: Insider sale
Amount: $2,590,489.2
Shares · price: 65,832 sh · $39.35 a share
Held after: 394,996 sh
Stock: Royalty Pharma RPRX
Person: Terrance P. CoyneEVP & CFO
Trade date: 26/01/20
Filed: 26/01/23
Days to filing: 3 days

Sold 14.3% of holdings

Share of holding sold: 14.3%

Royalty Pharma trades, last 26 weeks

What else happened in Royalty Pharma around then

Filed or reported within 30 days of the trade day · 25/12/21~02/19

Terrance P. Coyne's recent trades

Terrance P. CoyneEVP & CFO
Planned sale10b5-1 planRoyalty Pharma
Planned sale10b5-1 plan
Royalty Pharma
RPRX
$644.3K
11,002 sh
$644.3K
Filed 08/13
Traded 08/13
Terrance P. CoyneEVP & CFO
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$3.5M
64,399 sh
$3.5M
Filed 05/28
Traded 05/26
Terrance P. CoyneEVP & CFO
Planned sale10b5-1 planRoyalty Pharma
Planned sale10b5-1 plan
Royalty Pharma
RPRX
$3.5M
64,399 sh
$3.5M
Filed 05/26
Traded 05/26
Terrance P. CoyneEVP & CFO
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$1.6M
32,916 sh
$1.6M
Filed 04/30
Traded 04/28
Terrance P. CoyneEVP & CFO
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$93.3K
1,875 sh
$93.3K
Filed 04/30
Traded 04/28